Switching to a generic respiratory inhaler can seem like a cost-saving win-but without proper training, it can lead to worse symptoms and hospital visits. Learn why the device matters as much as the drug.
Author: Calder Renshaw
Patent expiration isn't the same worldwide. While 20 years from filing is the global standard, extensions, fees, and delays mean your patent may expire earlier or later depending on the country. Here's how it really works.
Learn where to find real side effect details for your prescription drugs. Understand the difference between FDA-required Medication Guides and full Package Inserts-and how to access both to stay safe.
Learn the critical signs of liver transplant rejection and why sticking to your medication schedule is the #1 factor in long-term survival. Real data, real stories, and practical steps to stay alive after transplant.
Understand 2025 Medicare Part D formulary changes, how generic and biosimilar switching affects your prescriptions, and what to do before your drug coverage changes. Save money without risking your health.
Counterfeit medications are a growing threat, with fake pills containing dangerous substances like fentanyl. Learn the top red flags - from suspicious pricing to packaging errors - to protect yourself and loved ones from deadly fake drugs.
Ringworm is a common fungal skin infection that looks like a red, circular rash. Learn how to identify it, which antifungal creams actually work, how to use them correctly, and how to prevent it from spreading or coming back.
Prescription drug misuse is rising among college students, especially stimulants like Adderall. Learn the risks, where pills come from, how to store and dispose of meds safely, and what schools are doing to help.
GLP-1 agonists like Wegovy and Zepbound can help people lose 15% or more of their body weight, but come with nausea, high costs, and the need for lifelong use. Learn how they work, who benefits, and what to expect.
Combination NTI drugs offer precise treatment for complex conditions but face major gaps in generic availability due to bioequivalence challenges. Patients risk therapeutic failure or toxicity when generics are substituted, with no FDA-approved fixed-dose NTI combinations currently on the U.S. market.